Source SEC Filings (10-K/10-Q)Updated Feb 9, 2026Currency USDFYE September
This page shows Anavex Life Scie (AVXL) financial statements, including the
income statement, balance sheet, cash flow statement, and key financial ratios.
View 13 years of annual fundamentals and quarterly data, with year-over-year
growth rates and compound annual growth rates (CAGR).
All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Piotroski F-ScoreWeak
1/9
Anavex Life Scie passes 1 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
Earnings QualityLow Quality
0.84x
For every $1 of reported earnings, Anavex Life Scie generates $0.84 in operating cash flow (-$39.0M OCF vs -$46.4M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Interest CoverageAt Risk
-11.0x
Anavex Life Scie earns $-11.0 in operating income for every $1 of interest expense (-$51.4M vs $4.7M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Anavex Life Scie reported -$46.4M in net income in fiscal year 2025. This represents a decrease of 7.8% from the prior year.
EPS (Diluted)
$-0.54
YoY-3.8%
Anavex Life Scie earned $-0.54 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 3.8% from the prior year.
Cash & Balance Sheet
Free Cash Flow
N/A
Cash & Debt
$102.6M
YoY-22.4%
5Y CAGR+28.5%
10Y CAGR+21.0%
Anavex Life Scie held $102.6M in cash against $0 in long-term debt as of fiscal year 2025.
Dividends Per Share
N/A
Shares Outstanding
87M
YoY+2.2%
5Y CAGR+6.9%
10Y CAGR+10.5%
Anavex Life Scie had 87M shares outstanding in fiscal year 2025. This represents an increase of 2.2% from the prior year.
Margins & Returns
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
-48.9%
YoY-13.1pp
5Y CAGR+47.6pp
10Y CAGR+45.6pp
Anavex Life Scie's ROE was -48.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 13.1 percentage points from the prior year.
Capital Allocation
R&D Spending
$37.6M
YoY-10.1%
5Y CAGR+8.3%
10Y CAGR+32.4%
Anavex Life Scie invested $37.6M in research and development in fiscal year 2025. This represents a decrease of 10.1% from the prior year.
No, Anavex Life Scie (AVXL) reported a net income of -$46.4M in fiscal year 2025.
What is Anavex Life Scie's earnings per share (EPS)?
Anavex Life Scie (AVXL) reported diluted earnings per share of $-0.54 for fiscal year 2025. This represents a -3.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Anavex Life Scie's return on equity (ROE)?
Anavex Life Scie (AVXL) has a return on equity of -48.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Anavex Life Scie's operating cash flow?
Anavex Life Scie (AVXL) generated -$39.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Anavex Life Scie's total assets?
Anavex Life Scie (AVXL) had $103.8M in total assets as of fiscal year 2025, including both current and long-term assets.
How much does Anavex Life Scie spend on research and development?
Anavex Life Scie (AVXL) invested $37.6M in research and development during fiscal year 2025.
How many shares does Anavex Life Scie have outstanding?
Anavex Life Scie (AVXL) had 87M shares outstanding as of fiscal year 2025.
What is Anavex Life Scie's debt-to-equity ratio?
Anavex Life Scie (AVXL) had a debt-to-equity ratio of 0.09 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Anavex Life Scie's return on assets (ROA)?
Anavex Life Scie (AVXL) had a return on assets of -44.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Anavex Life Scie's cash runway?
Based on fiscal year 2025 data, Anavex Life Scie (AVXL) had $102.6M in cash against an annual operating cash burn of $39.0M. This gives an estimated cash runway of approximately 32 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Anavex Life Scie's Piotroski F-Score?
Anavex Life Scie (AVXL) has a Piotroski F-Score of 1 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Anavex Life Scie's earnings high quality?
Anavex Life Scie (AVXL) has an earnings quality ratio of 0.84x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Anavex Life Scie cover its interest payments?
Anavex Life Scie (AVXL) has an interest coverage ratio of -11.0x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
